Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc.
Also tagged Innovations, Lisbon Portugal, Management Technologies Inc, Study Presentation, Subsidiary, Wound Care, Wound Management
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced that its subsidiary Wound Care Innovations, LLC will exhibit at the 24th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing, which opens on October 22 in San Antonio. [...]
Also tagged Amp, Clinical Symposium, Conference Management, Innovations, Management Technologies Inc, Medical Products, Otc Bulletin Board, Presentation Technology, Prevention, San Antonio, Skin Care, Specialty Products, Study Presentation, Subsidiary, Wound Care, Wound Management
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit. Developed by physician Damon Borich, M.D., CEO of Reveal Sciences, and his scientific team, the novel skincare analysis technology is the next-generation spin-off from the company’s professional [...]
Also tagged Aesthetics, Analysis Kit, Analysis Technology, Breakthrough, Care Diagnostics, Ceo, Consumers, Cosmetics Company, Innovation Company, Launch, Launches, New Skin, Next Generation, Novel Analysis, Skin Care, Skincare, Typing
Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz’s premarket approval (PMA) application for Belotero(R) Balance. Belotero(R) Balance is a hyaluronic acid based monophasic gel dermal filler that utilizes a cohesive polydensified matrix (CPM(TM)) technology.
Also tagged Company Announced That, Dermal Filler, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Hyaluronic Acid, Matrix, Merz Pharmaceuticals, Pharmaceutical Company, Premarket Approval
IMULAN BioTherapeutics, LLC announced they are prepared to commence with regulated trials to complete work on the T-Cell Receptor peptide immunomodulator, for atopic dermatitis in dogs. Canine atopic dermatitis is a very prevalent condition in dogs, thought to affect up to 5 percent of the dog population. Clinical signs of atopic dermatitis include pruritus (itching) [...]
Also tagged Atopic Dermatitis, Clinical Signs, Dermatitis, Dogs, Immunomodulator, Peptide, Population, Prevalent Condition, Pruritus Itching, Pyoderma, Skin Infections, T Cell Receptor, Topical Skin
Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it will exhibit at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) conference in Dallas April 26-29. This conference is regarded industry wide as the premier educational wound-care focused program and has [...]
Also tagged Advanced Wound Care, Care Clinicians, Innovations, Management Technologies Inc, Otc Bulletin Board, Presentation, Subsidiary, Symposium, United States, Wound Healing Society, Wound Management
American Biotech Labs, LLC (ABL), developer of a new class of products based on the company’s patented nano-catalytic SilverSol Technology(R), announced that the company has been granted formal approval by the U.S. Food and Drug Administration (FDA) to market its ASAP Wound Dressing Gel throughout the United States.
Also tagged Biotech Labs, Developer, Fda, Fda Approval, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Formal Approval, New Wound, Technology, United States, Wound Care, Wound Dressing
